Targeting the androgen receptor (AR) in women with AR+ ER-/PR- metastatic breast cancer (MBC).
Ayca Gucalp
No relevant relationships to disclose
Sara M. Tolaney
No relevant relationships to disclose
Steven J. Isakoff
No relevant relationships to disclose
James N. Ingle
No relevant relationships to disclose
Minetta C. Liu
No relevant relationships to disclose
Lisa A. Carey
No relevant relationships to disclose
Kimberly L. Blackwell
No relevant relationships to disclose
Hope S. Rugo
Research Funding - Genentech; GlaxoSmithKline; ImClone Systems; Merck; Novartis; Sanofi
Lisle Nabell
No relevant relationships to disclose
Andres Forero-Torres
No relevant relationships to disclose
Vered Stearns
Honoraria - AstraZeneca
Research Funding - Celgene; Merck; Novartis; Pfizer
Lamia Momen
No relevant relationships to disclose
Joseph Gonzalez
No relevant relationships to disclose
Dilip D. Giri
No relevant relationships to disclose
Sujata Patil
No relevant relationships to disclose
Kimberly Feigin
No relevant relationships to disclose
Clifford Hudis
No relevant relationships to disclose
Tiffany A. Traina
Honoraria - Ipsen